A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a ...

Shares of CVS Health Corp. continued climbing premarket Thursday after a blockbuster session driven by stronger-than-expected ...

BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

Larry McGrath; Executive Vice President, Chief Strategy Officer and Chief Strategic Advisor to the CEO of CVS Health; CVS Health Corp David Joyner; President and Chief Executive Officer; CVS Health ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...

CVS Health executives cited tech-enabled home care provider Signify Health and primary care entity Oak Street for helping to generate profit growth in the fourth quarter of 2024.

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...